Locations:
SearchAdvertisement
AHA recommendations for pretransplant evaluation, peritransplant and long-term management
Cleveland Clinic Cancer Institute among select group of centers to administer highly personalized treatment
Real-world results reporting aims to make treatments safer and more effective
Ongoing clinical validation in diverse populations refine breast cancer risk substratification
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Soft tissue pathologist discusses research into incorporating genomic data to improve risk stratification
Research program sets the stage for clinical trials
Researchers use AI tools to compare clinical events with continuous patient monitoring
Prediction and bioinformatic data could prove valuable for therapeutic interventions targeting this malignancy
Study measures real-world outcomes for relapsed or refractory large B-cell lymphoma
Optimized responses in transplant- and CAR T-cell therapy-eligible patients
Advertisement
Advertisement